A study from Dana-Farber Cancer Institute reveals that patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range. The research was presented at the annual meeting of the American Society of Hematology. "This is good evidence that age alone should not limit who should get a transplant for MDS," said Gregory Abel, MD, MPH, a medical oncologist at Dana-Farber. "Calendar ...
Read MoreYou have just read an article categorized health
titled Study Urges Age Should Not Prevent Access to Transplants for MDS.
Written by:
editor - Sunday, December 8, 2013
There are currently no comments for "Study Urges Age Should Not Prevent Access to Transplants for MDS"
Post a Comment